Hello reader!

Market updates are typically not planned during the month. However, in what is becoming a pattern during the fourth quarter, the unrelenting volatility in stocks is forcing a constant reevaluation.

At this time, 2 positions will be closed in the model portfolio to reduce the market exposure to 70% from 90%. The 2 positions are:

 -  TRVG
 -  CROX

Even good stocks can struggle in a bad market. Thus far, the Correction related volatility of downside and upside moves has been similar to the ones experienced in the past few years. As the market once again approaches the bottom of its range in a zig-zag pattern, it will provide new insights on whether it can once again reverse and move higher or not. Further risk reduction may be required during the month. 

There is a fog of concerns that has rolled-in which is beginning to cloud the investment visibility. Earnings concerns for 2019 and the anxiety of an over-active monetary policy are legitimate concerns. But the market sentiment has transformed to a point where most news is being perceived as bad news or in other words a glass-half-full sentiment. Consumer spending remains strong, the employment market remains strong, and the Federal Reserve has indicated it is now closer to achieving a neutral threshold where further policy action, or interest rate hikes, may not even be required in the first quarter of next year. But the negative sentiment dominates for the time being, and this market condition will require patience to resolve.

We will continue to monitor and make any further adjustments to the model portfolio during the month if required.

For any questions, kindly contact us at support@GraycellAdvisors.com or use the Contact form.

Sincerely,
Graycell Advisors

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Prudent Biotech and Smallcap newsletters. Historical performance figures provided are hypothetical and unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period of time. The performance results obtained are intended for illustrative purposes only. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, smallcap segment is characterized by much higher risk and volatility than the general stock market. The Information contained herein does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your own investment decisions. We are not liable nor do we assume any responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium.  We also cannot guarantee the accuracy and completeness of any information furnished by us. Graycell is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. We may or may not already have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment and consider obtaining professional advice before making an investment decision.